{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:50:44Z","timestamp":1759539044096,"version":"build-2065373602"},"reference-count":42,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Food and Chemical Toxicology"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.fct.2008.07.006","type":"journal-article","created":{"date-parts":[[2008,7,23]],"date-time":"2008-07-23T04:22:41Z","timestamp":1216786961000},"page":"3186-3192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Investigating the potential neuroprotective effects of statins on DNA damage in mouse striatum"],"prefix":"10.1016","volume":"46","author":[{"given":"T.N.","family":"Coetsee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.J.","family":"Pretorius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Terre\u2019Blanche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.J.","family":"Bergh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fct.2008.07.006_bib1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1023\/A:1015591628503","article-title":"Distribution of coenzyme Q homologues in brain","volume":"27","author":"Albano","year":"2002","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.fct.2008.07.006_bib2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0021-9150(98)00032-X","article-title":"Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation","volume":"138","author":"Aviram","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.fct.2008.07.006_bib3","first-page":"218","article-title":"Biochemical and clinical consequences of CoQ10 biosynthesis by lipid-lowering HMG-CoA reductase inhibitors (statins): A critical review","volume":"15","author":"Bliznakov","year":"1998","journal-title":"Adv. Therap."},{"key":"10.1016\/j.fct.2008.07.006_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0014-4886(02)00045-6","article-title":"Dependence on electron transport chain function and intracellular signaling of genomic responses in SH-SY5Y cells to the mitochondrial neurotoxin MPP+","volume":"18","author":"Brill","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.fct.2008.07.006_bib5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0925-4439(97)00070-7","article-title":"Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson\u2019s disease","volume":"1362","author":"Cassarino","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.fct.2008.07.006_bib6","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1212\/WNL.51.2_Suppl_2.S30","article-title":"Neostriatal mechanisms in Parkinson\u2019s disease","volume":"51","author":"Chase","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.fct.2008.07.006_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-7258(98)00016-3","article-title":"Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in transplant patients: are the statins mechanistically similar?","volume":"80","author":"Christians","year":"1998","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.fct.2008.07.006_bib8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1385\/MB:26:3:249","article-title":"The Comet Assay for DNA damage and repair: principles, applications, and limitations","volume":"26","author":"Collins","year":"2004","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.fct.2008.07.006_bib9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cca.2005.09.009","article-title":"Does measurement of oxidative damage to DNA have clinical significance?","volume":"365","author":"Cooke","year":"2006","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.fct.2008.07.006_bib10","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.7901908","article-title":"Oxidative stress, glutamate, and neurodegenerative disorders","volume":"262","author":"Coyle","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.fct.2008.07.006_bib11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0022-510X(01)00529-9","article-title":"Use of statins in CNS disorders","volume":"187","author":"Cucchiara","year":"2001","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.fct.2008.07.006_bib12","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/sj.bjp.0706953","article-title":"Lovastatin protects human endothelial cells from the genotoxic and cytotoxic effects of the anticancer drugs doxorubicin and etoposide","volume":"149","author":"Damrot","year":"2006","journal-title":"Brit. J. Pharmacol."},{"key":"10.1016\/j.fct.2008.07.006_bib13","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.freeradbiomed.2008.03.005","article-title":"Oxidative and nitrative protein modifications in Parkinson\u2019s disease","volume":"44","author":"Danielson","year":"2008","journal-title":"Free Radical Bio. Med."},{"key":"10.1016\/j.fct.2008.07.006_bib14","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/j.freeradbiomed.2008.02.008","article-title":"Role of reactive oxygen species in the neurotoxicity of environmental agents implicated in Parkinson\u2019s disease","volume":"44","author":"Drechsel","year":"2008","journal-title":"Free Radical Bio. Med."},{"key":"10.1016\/j.fct.2008.07.006_bib15","series-title":"Basic neurochemistry: molecular, cellular and medical aspects","first-page":"711","article-title":"Hypoxic-ischemic brain injury and oxidative stress","author":"Dugan","year":"1999"},{"key":"10.1016\/j.fct.2008.07.006_bib16","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0731-7085(03)00408-4","article-title":"An HPLC method for the determination of atorvastatin and its impurities in bulk drug and tablets","volume":"33","author":"Ert\u00fcrk","year":"2003","journal-title":"J. Pharmaceut. Biomed."},{"issue":"5","key":"10.1016\/j.fct.2008.07.006_bib17","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/(SICI)1097-4547(19990301)55:5<620::AID-JNR9>3.0.CO;2-S","article-title":"Characterization and time course of MPP+-induced apoptosis in human SH-SY5Y neuroblastoma cells","volume":"55","author":"Fall","year":"1999","journal-title":"J. Neurosci Res."},{"key":"10.1016\/j.fct.2008.07.006_bib18","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0167-5273(02)00577-6","article-title":"A comparative study of the in vitro antioxidant activity of statins","volume":"90","author":"Franzoni","year":"2003","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.fct.2008.07.006_bib19","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0026-895X(25)13535-9","article-title":"Oxidative pathway for catecholamines in the genesis of neuromelanin and cytotoxic quinones","volume":"14","author":"Graham","year":"1978","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.fct.2008.07.006_bib20","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0026-895X(25)13536-0","article-title":"Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro","volume":"14","author":"Graham","year":"1978","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.fct.2008.07.006_bib21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0165-6147(97)01147-4","article-title":"Hydrophilicity\/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors","volume":"19","author":"Hamelin","year":"1998","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.fct.2008.07.006_bib22","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/glia.440150412","article-title":"Differential regulation by cytokines of human astrocyte nitric oxide production","volume":"15","author":"Hu","year":"1995","journal-title":"Glia"},{"key":"10.1016\/j.fct.2008.07.006_bib23","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0009-8981(97)06557-1","article-title":"The effect of Simvastatin on the plasma antioxidant concentrations in patients with hypercholesterolaemia","volume":"263","author":"Human","year":"1997","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.fct.2008.07.006_bib24","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1212\/01.WNL.0000095209.59347.79","article-title":"A2A antagonists as novel non-dopaminergic therapy for motor dysfunction in Parkinson\u2019s disease","volume":"61","author":"Jenner","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.fct.2008.07.006_bib25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0022-510X(95)00210-S","article-title":"The role of transition metals in the pathogenesis of Parkinson\u2019s disease","volume":"134","author":"Kienzl","year":"1995","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.fct.2008.07.006_bib26","first-page":"70","article-title":"Predicting Parkinson\u2019s disease","volume":"40","author":"Langston","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.fct.2008.07.006_bib27","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.steroids.2004.03.012","article-title":"High doses of simvastatin, pravastatin, and cholesterol reduce brain cholesterol synthesis in guinea pigs","volume":"69","author":"L\u00fctjohann","year":"2004","journal-title":"Steroids"},{"key":"10.1016\/j.fct.2008.07.006_bib28","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/carcin\/21.3.361","article-title":"Oxyradicals and DNA damage","volume":"21","author":"Marnett","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.fct.2008.07.006_bib29","first-page":"277","article-title":"Changes in cytokines and neurotrophins in Parkinson\u2019s disease","volume":"60","author":"Nagatsu","year":"2000","journal-title":"J. Neural Transm.-Supp."},{"key":"10.1016\/j.fct.2008.07.006_bib30","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1172\/JCI119812","article-title":"Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages","volume":"100","author":"Pahan","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.fct.2008.07.006_bib31","first-page":"113","article-title":"Parkinson\u2019s disease: a multifactorial neurodegenerative disorder","volume":"56","author":"Riess","year":"1999","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.fct.2008.07.006_bib32","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0891-5849(97)00457-7","article-title":"Cellular mechanisms of resistance to chronic oxidative stress","volume":"24","author":"Sagara","year":"1997","journal-title":"Free Radical Bio. Med."},{"key":"10.1016\/j.fct.2008.07.006_bib33","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s007020100004","article-title":"Neurochemical findings in the MPTP model of Parkinson\u2019s disease","volume":"108","author":"Schmidt","year":"2001","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.fct.2008.07.006_bib34","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cccn.2005.04.001","article-title":"A beneficial effect of simvastatin on DNA damage in 242T allele of NADPH oxidase p22phox in hypercholesterolemic patients","volume":"360","author":"Shin","year":"2005","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.fct.2008.07.006_bib35","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ana.410360305","article-title":"Alterations in glutathione levels in Parkinson\u2019s disease and other neurodegenerative disorders affecting basal ganglia","volume":"36","author":"Sian","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.fct.2008.07.006_bib36","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0027-5107(00)00075-0","article-title":"Microgels for estimation of DNA strand breaks, DNA protein crosslinks and apoptosis","volume":"455","author":"Singh","year":"2000","journal-title":"Mutat. Res-Fund. Mol. M."},{"key":"10.1016\/j.fct.2008.07.006_bib37","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0892-0362(02)00222-2","article-title":"MPTP: insights into neurodegeneration","volume":"24","author":"Speciale","year":"2002","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.fct.2008.07.006_bib38","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/01.STR.30.9.1969","article-title":"Neuroprotective properties of statins in cerebral ischemia and stroke","volume":"30","author":"Vaughan","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.fct.2008.07.006_bib39","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1084\/jem.184.4.1425","article-title":"Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer\u2019s disease","volume":"184","author":"Vodovotz","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.fct.2008.07.006_bib40","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.pneurobio.2004.05.002","article-title":"Genes, proteins, and neurotoxins involved in Parkinson\u2019s disease","volume":"73","author":"Von Bohlen und Halbach","year":"2004","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.fct.2008.07.006_bib41","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/archneur.57.10.1439","article-title":"Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors","volume":"57","author":"Wolozin","year":"2000","journal-title":"Arch. Neurol-Chicago"},{"key":"10.1016\/j.fct.2008.07.006_bib42","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000118539","article-title":"Free radicals and their scavengers in Parkinson\u2019s disease","volume":"33","author":"Yoshikawa","year":"1993","journal-title":"Eur. Neurol."}],"container-title":["Food and Chemical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691508003992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691508003992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T20:44:23Z","timestamp":1759524263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278691508003992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0278691508003992"],"URL":"https:\/\/doi.org\/10.1016\/j.fct.2008.07.006","relation":{},"ISSN":["0278-6915"],"issn-type":[{"type":"print","value":"0278-6915"}],"subject":[],"published":{"date-parts":[[2008,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigating the potential neuroprotective effects of statins on DNA damage in mouse striatum","name":"articletitle","label":"Article Title"},{"value":"Food and Chemical Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fct.2008.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}